Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:e127-e133

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Amerongen, G. P. v. N.
Right arrow Articles by van Hinsbergh, V. W. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amerongen, G. P. v. N.
Right arrow Articles by van Hinsbergh, V. W. M.
Related Collections
Right arrow Pathophysiology
Right arrow Cell signalling/signal transduction
Right arrow Endothelium/vascular type/nitric oxide
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:e127.)
© 2000 American Heart Association, Inc.


Vascular Biology

Role of RhoA and Rho Kinase in Lysophosphatidic Acid–Induced Endothelial Barrier Dysfunction

Geerten P. van Nieuw Amerongen; Mario A. Vermeer; Victor W. M. van Hinsbergh

From the Gaubius Laboratory TNO-PG (G.P.v.N.A., M.A.V., V.M.M.v.H.), Leiden, and the Department of Physiology (G.P.v.N.A., V.M.M.v.H.), Institute for Cardiovascular Research, Vrije Universiteit, Amsterdam, The Netherlands.

Correspondence to Prof Dr V.W.M. van Hinsbergh, Gaubius Laboratory TNO-PG, PO Box 2215, 2301 CE Leiden, the Netherlands. E-mail vwm.vanhinsbergh{at}pg.tno.nl

Abstract—In the present study, the roles of the small GTPase RhoA and its target Rho kinase in endothelial permeability were investigated in vitro. We have shown previously that, in addition to a rise in the intracellular Ca2+ concentration ([Ca2+]i), RhoA is involved in the prolonged thrombin-induced barrier dysfunction. To study the role of RhoA and Rho kinase more specifically, endothelial cells were stimulated with lysophosphatidic acid (LPA), a commonly used RhoA activator. LPA induced a 2- to 3-fold increase in the passage of horseradish peroxidase (HRP) across endothelial monolayers that lasted for several hours, whereas thrombin induced a 5- to 10-fold increase. Comparable to the thrombin-induced barrier dysfunction, the LPA-induced barrier dysfunction was accompanied by a reorganization of the F-actin cytoskeleton and the formation of focal attachment sites. LPA induced only a transient increase in myosin light-chain (MLC) phosphorylation, which returned to basal level within 10 minutes. In endothelial cells, [Ca2+]i was not elevated by LPA. Chelation of Ca2+i ions by 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid did not prevent the LPA-induced passage of HRP. Apparently, a low degree of MLC kinase activation occurred, because the MLC kinase inhibitor KT5926 reduced the levels of both basal and LPA-stimulated HRP passage. Inhibition of RhoA by the C3 transferase from Clostridium botulinum inhibited the LPA-induced cytoskeletal changes and prevented the LPA-induced HRP passage. Inhibition of Rho kinase by Y-27632 completely prevented the LPA-induced increase in HRP passage without affecting basal permeability. These data indicate that LPA-induced endothelial hyperpermeability occurs without a change in [Ca2+]i and requires activation of RhoA and Rho kinase.


Key Words: human endothelial cells • RhoA • calcium • myosin light-chain phosphorylation • myosin light-chain kinase




This article has been cited by other articles:


Home page
IOVSHome page
K.-P. Xu, J. Yin, and F.-S. X. Yu
Lysophosphatidic Acid Promoting Corneal Epithelial Wound Healing by Transactivation of Epidermal Growth Factor Receptor
Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 636 - 643.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
F. L. Minnear, S. Patil, D. Bell, J. P. Gainor, and C. A. Morton
Platelet lipid(s) bound to albumin increases endothelial electrical resistance: mimicked by LPA
Am J Physiol Lung Cell Mol Physiol, December 1, 2001; 281(6): L1337 - L1344.
[Abstract] [Full Text] [PDF]